Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells

Circulation Research

Volumn 87, Issue 5, 2000, Pages 370-377

  Willam, Carsten ^a   Koehne, Petra ^a   Jürgensen, Jan Steffen ^a   Gräfe, Michael ^b   Wagner, Kay Dietrich ^a   Bachmann, Sebastian ^a   Frei, Ulrich ^a   Eckardt, Kai Uwe ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokines; Endothelium; Hypoxia; Receptor; Tie2; Tyrosine kinase

Indexed keywords

TYROSINE KINASE RECEPTOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 0034283046     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.5.370     Document Type: Article

References (42)

1. Endothelial receptor tyrosine kinases involved in angiogenesis
2. Signaling vascular morphogenesis and maintenance
3. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
4. The biology of vascular endothelial growth factor
5. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development
6. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
7. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
8. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
9. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
10. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
11. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
12. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
13. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
14. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
15. Endothelial-specific gene expression directed by the tie gene promoter in vivo
16. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice
17. Cloning and partial characterization of the human tie-2 receptor tyrosine kinase gene promoter
18. Oxygen sensing and molecular adaptation to hypoxia
19. Oxygen(es) and the hypoxia-inducible factor-1
20. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
21. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
22. Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells
23. Macrophages and Angiogenesis
24. The codependence of angiogenesis and chronic inflammation
25. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
26. Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts
27. Increases in oxygen tension stimulate the expression of ICAM-1 and VCAM-I on human endothelial cells
28. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
29. Effects of culture conditions on the proliferation, morphology and migration of bovine aortic endothelial cells
30. Decreased susceptibility of contractile function to hypoxia/reoxygenation in chronic infarcted rat hearts
31. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors
32. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
33. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
34. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
35. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
36. Vascular endothelial growth factor and the angiopoietins: Working together to build a better blood vessel
37. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
38. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
39. HIF-1α is required for solid tumor formation and embryonic vascularization
40. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tuinor growth
41. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
42. 2 homeostasis by hypoxia-inducible factor 1α